Annual Report

Overview

The report describes Afreximbank's response to the COVID-19 pandemic, including its US$2 billion vaccine-financing facility supporting the procurement of Johnson & Johnson doses. It highlights the launch of a US$6.5 billion General Capital Increase to expand the Bank's capacity across Africa. The report also records the operational rollout of the Pan-African Payment and Settlement System (PAPSS) and continued AfCFTA-related initiatives. For the first time, the report presents consolidated Group results including FEDA companies and AfrexInsure.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 26 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services